Lipid lowering effect of fulvestrant in hormone-sensitive metastatic breast cancer patients

被引：0
|
作者：
Camerini, A.
Amoroso, D.
Garrone, O.
Vincenti, M.
Tartarelli, G.
Donati, S.
Valsuani, C.
Siclari, O.
Mattiot, V. Polla
Sgambato, A.
机构：
[1] Osped Versilia, Lido Di Camaiore, LU, Italy
[2] Ist Toscano Tumori, Lido Di Camaiore, LU, Italy
[3] Osped Santa Croce, Cuneo, Italy
[4] Osped Inferm Biella, Biella, Italy
[5] Univ Cattolica, Rome, Italy
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1085
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Systemic therapy in metastatic hormone-sensitive prostate cancer
    McDonald, Jodie
    O'Brien, Jonathan
    Kostos, Louise
    Lawrentschuk, Nathan
    Azad, Arun A.
    Murphy, Declan
    Chen, Kenneth
    CURRENT OPINION IN SUPPORTIVE AND PALLIATIVE CARE, 2022, 16 (04) : 234 - 239
  • [42] Treatment options for metastatic hormone-sensitive prostate cancer
    Kostos, Louise
    Murphy, Declan G.
    LANCET ONCOLOGY, 2022, 23 (10): : 1234 - 1235
  • [43] Results from a pilot study of goserelin plus fulvestrant in premenopausal women with advanced, hormone-sensitive breast cancer
    Steger, G.
    Bartsch, R.
    Wenzel, C.
    Hussain, D.
    Sevelda, U.
    Pluschnig, U.
    Mader, R.
    Zielinski, C.
    EJC SUPPLEMENTS, 2005, 3 (02): : 127 - 128
  • [44] Fulvestrant (FUL) and goserelin (GOS) in premenopausal women with advanced, hormone-sensitive breast cancer: A pilot study.
    Steger, G
    Bartsch, R
    Wenzel, C
    Hussian, D
    Sevelda, U
    Pluschnig, U
    Mader, R
    Zielinski, CC
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 55S - 55S
  • [45] Disease-related complications in patients with metastatic hormone-sensitive prostate cancer
    Ng, C. F.
    Mak, Christy W. H.
    Chan, Samson Y. S.
    Li, M. L.
    Leung, C. H.
    Teoh, Jeremy Y. C.
    Chiu, Peter K. F.
    Chu, Peggy S. K.
    HONG KONG MEDICAL JOURNAL, 2023, 29 (04) : 324 - 329
  • [46] Docetaxel, abiraterone, enzalutamide, apalutamide in patients with metastatic hormone-sensitive prostate cancer
    Talwar, Harkirat Singh
    INDIAN JOURNAL OF UROLOGY, 2021, 37 (03) : 288 - 290
  • [47] Synergistic molecular mechanisms in hormone-sensitive breast cancer
    Cussac, Antonio Llombart
    NEW TRENDS IN CANCER FOR THE 21ST CENTURY, 2ND EDITION, 2006, 587 : 375 - 386
  • [48] The importance of distant metastases in hormone-sensitive breast cancer
    Rugo, Hope S.
    BREAST, 2008, 17 : S3 - S8
  • [49] Re: Darolutamide and Survival in Metastatic, Hormone-sensitive Prostate Cancer
    Olivier, Timothee
    Tsantoulis, Petros
    Prasad, Vinay
    EUROPEAN UROLOGY, 2023, 83 (06) : 584 - 585
  • [50] Optimal Pharmacotherapeutic Management of Hormone-Sensitive Metastatic Prostate Cancer
    Ajjai Alva
    Maha Hussain
    Drugs, 2013, 73 : 1517 - 1524
12345